Canonic

Company Overview

Snapshot

Founded in March 2019, Canonic operated with 1–10 employees. The company focused on developing medical-grade cannabis products using a genomic approach. In October 2021, Canonic announced the full commercial launch of its first medical cannabis products in Israel.

Business overview

Canonic, a subsidiary of Evogene, develops medical-grade cannabis products by leveraging a genomic approach. The company utilizes Evogene's computational predictive biology platform to create improved cannabis varieties with a focus on yield, stability, and specific metabolite composition. Canonic operates within the Agriculture & Food Technologies sector, specifically in Ag Tech and Genetics & Input, and serves the Pharmaceuticals market.

Strategic signal

In October 2021, Canonic announced the full commercial launch of its first medical cannabis products in Israel. This milestone signaled the company's transition from development to market entry, validating its genomic approach to medical cannabis and indicating a readiness to capture market share in the Israeli medical cannabis sector.

Company Intelligence Q&A

What is Canonic's primary focus?

Canonic aims to develop and bring to market medical-grade cannabis products using a genomic approach, focusing on improving cannabis varieties for yield, stability, and specific metabolite composition.

When did Canonic launch its first medical cannabis products?

Canonic announced the full commercial launch of its first medical cannabis products in Israel in October 2021.

What was the nature of Canonic's agreement with Hadassah Medical Center?

In January 2020, Canonic announced an agreement with Hadassah Medical Center for pre-clinical studies to support the development of its medical cannabis products.

What collaboration did Canonic announce in February 2021?

In February 2021, Canonic announced a collaboration with Cannbit, a subsidiary of Tikun Olam-Cannbit, for the development of novel medical cannabis products.

When did Canonic receive approval for medical cannabis propagation?

In November 2020, Canonic received approval for the propagation of medical cannabis from the Israel Medical Cannabis Agency.